Waters Corp /De/ (WAT) Stock Price & Analysis
Waters Corp /De/ (WAT) rose 2.15% to USD 371.15 as of June 9, 2026 at 23:44 UTC, according to Nexqual real-time market data.
WAT last closed at USD 363.34; the session ranged USD 368.82–377.25 on volume of 753,437 shares. Market capitalization is $36.44B, with a 52-week range of USD 275.05–414.15 (NYQ). Source: Nexqual, June 9, 2026 at 23:44 UTC.
Key Statistics (as of June 9, 2026 at 23:44 UTC)
| Price | USD 371.15 |
|---|---|
| Change | ▲ 2.15% (up) |
| Previous Close | USD 363.34 |
| Open | USD 367.94 |
| Day Range | USD 368.82 – 377.25 |
| 52-Week Range | USD 275.05 – 414.15 |
| Volume | 753,437 shares |
| Market Cap | $36.44B |
| Exchange | NYQ |
Technical Analysis (WAT)
Nexqual's technical model rates WAT "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 9, 2026 at 23:44 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 58.63 (neutral) |
| vs SMA50 | Above (USD 333.03) |
| MACD | 11.88 (positive) |
Analyst Ratings (WAT)
Wall Street analysts rate WAT "Buy" based on 21 analysts, with a mean price target of USD 400.29 (range USD 345–460), per Nexqual as of June 9, 2026 at 23:44 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 21 |
| Mean Target | USD 400.29 |
| High Target | USD 460 |
| Low Target | USD 345 |
| Buy / Hold / Sell | 14 / 8 / 0 |
Earnings (WAT)
| Next Earnings Date | 2026-07-29 |
|---|---|
| EPS Estimate | USD 3.01 |
| Revenue Estimate | $1.62B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 2.7 vs est 2.31 ▲ beat |
| 2025-12-31 | USD 4.53 vs est 4.51 ▲ beat |
| 2025-09-30 | USD 3.4 vs est 3.22 ▲ beat |
| 2025-06-30 | USD 2.95 vs est 2.94 ▲ beat |
Source: Nexqual, June 9, 2026 at 23:44 UTC.
Financials & Fundamentals (WAT)
| Total Revenue | $3.77B |
|---|---|
| Revenue Growth (YoY) | +91.40% |
| Gross Margin | +55.15% |
| Operating Margin | +2.84% |
| Profit Margin | +11.93% |
| ROE | +5.21% |
| Debt / Equity | 36.63 |
| Current Ratio | 1.79 |
| Total Cash | $462.00M |
| Total Debt | $5.60B |
| Free Cash Flow | $-502.37M |
Source: Nexqual, June 9, 2026 at 23:44 UTC.
Financial Health Score (WAT)
Nexqual rates Waters Corp /De/'s overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 23:44 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 55%, operating 3% |
| Balance Sheet | Solid — $462M cash vs $5.60B debt |
| Cash Flow | Weak — FCF negative: -$502M, burning cash |
| Efficiency | Mixed — ROE 5%, ROA 3.3% |
Ownership (WAT)
| Insider Ownership | +0.10% |
|---|---|
| Institutional Ownership | +99.67% |
| Shares Outstanding | 98.19M |
| Float | 98.00M |
| Short % of Float | +4.01% |
Source: Nexqual, June 9, 2026 at 23:44 UTC.
Leadership (WAT)
Waters Corp /De/ is led by Udit Batra (age 54), President, CEO & Director, per Nexqual as of June 9, 2026 at 23:44 UTC.
| President, CEO & Director | Udit Batra (age 54) |
|---|---|
| Senior VP & CFO | Amol Chaubal (age 48) |
| Senior Vice President of Waters Advanced Diagnostics | Jianqing Y. Bennett (age 55) |
| Senior Vice President of Waters Analytical Sciences | Robert L. Carpio (age 42) |
| Senior Vice President of Global Operations | Christos Ross |
Major Backers & Investors (WAT)
Notable institutional backers of Waters Corp /De/ include T. Rowe Price, Massachusetts Financial Services Co., Fundsmith LLP, according to Nexqual as of June 9, 2026 at 23:44 UTC.
Active Investors
| Investor | Stake |
|---|---|
| T. Rowe Price | 7.55% |
| Massachusetts Financial Services Co. | 4.72% |
| Fundsmith LLP | 3.27% |
| Invesco | 2.21% |
| Alliancebernstein L.P. | 2.16% |
| Fidelity | 1.28% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 19.98% |
| BlackRock | 9.99% |
| State Street | 5.63% |
| Geode Capital | 2.7% |
Source: Nexqual, June 9, 2026 at 23:44 UTC.
From Waters Corp /De/'s Latest SEC 10-K Filing (filed 2026-02-23)
Key Strengths & Strategy (as disclosed to the SEC)
- Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.
- The company operates through two segments, Waters and TA.
- The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products.
- It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MTD | Mettler-Toledo International, I | USD 1,162.79 | ▲ 0.73% |
| COO | The Cooper Companies, Inc. | USD 68.62 | ▲ 1.9% |
| XRAY | DENTSPLY SIRONA Inc. | USD 10.47 | ▲ 4.7% |
| LH | Labcorp Holdings Inc. | USD 271.24 | ▲ 2.3% |
| UHS | Universal Health Services, Inc. | USD 146.59 | ▲ 0.98% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:44 UTC. This page is informational and not investment advice.